Prot# HBS701: A Phase 1, Multi-Center, Randomized, Double-Blind, Sequential, Placebo Controlled Study of the Tolerability and Systemic Absorption of Menadione Topical Lotion as an Emergent and Pre-Emergent Treatment for Epidermal-Growth-Factor-Receptor (E

Project: Research project

Project Details

StatusFinished
Effective start/end date2/14/08 → 2/14/14

Funding

  • Camargo Pharmaceutical Services, LLC (HBS701)
  • Hana Biosciences, Inc. (HBS701)